Your Areas of Interest in Adverse Effects
Exit this survey
1.
1
. Which Cochrane Review Groups would you be interested in helping or advising?
Which Cochrane Review Groups would you be interested in helping or advising?
Acute Respiratory Infections
Airways
Anaesthesia
Back
Bone, Joint & Muscle Trauma
Breast Cancer
Childhood Cancer
Colorectal Cancer
Consumers & Communication
Cystic Fibrosis & Genetic Disorders
Dementia & Cognitive Improvement
Depression, Anxiety & Neurosis
Developmental, Psychosocial & Learning Problems
Drugs & Alcohol
Ear, Nose & Throat Disorders
Effective Practice & Organisation of Care
Epilepsy
Eyes & Vision
Fertility Regulation
Gynaecological Cancer
Haematological Malignancies
Heart
Hepato-Biliary
HIV/AIDS
Hypertension
Incontinence
Infectious Diseases
Inflammatory Bowel Disease & Functional Bowel Disorders
Injuries
Lung Cancer
Menstrual Disorders & Subfertility
Metabolic & Endocrine Disorders
Movement Disorders
Multiple Sclerosis
Musculoskeletal
Neonatal
Neuromuscular Disease
Oral Health
Pain, Palliative & Supportive Care
Peripheral Vascular Diseases
Pregnancy & Childbirth
Prostatic Diseases & Urologic Cancers
Public Health
Renal
Schizophrenia
Sexually Transmitted Diseases
Skin
Stroke
Tobacco Addiction
Upper Gastrointestinal & Pancreatic Diseases
Wounds
None of the above
Any comments
2
. Do you have a methodological area of interest?
Do you have a methodological area of interest?
Preclinical animal toxiciology
Preclinical human toxicology
Gathering and analysing spontaneous reports
Information retrieval methods
Assessment of causality
Describing the characteristics and natural history of adverse effects
Investigating and discovering the pharmalogical/biological mechanisms involved
Pharmacoepidemiology of the effect: frequency, seriousness and risk factors
Working out possible ways of preventing or attentuating adverse effects
Developing treatments for reversing harmful effects
Incorporating non-randomised studies of adverse effects
Weighing up benefits and harmful effects
Evidence synthesis of adverse effects data
Communicating knowledge to health professionals
Communicating knowledge to the public
Checking that new knowledge is used in practice
None of the above
Other (please specify)
3
. What populations and contexts of healthcare concern you the most?
What populations and contexts of healthcare concern you the most?
Child health
Complementary medicine
Consumers
Developing countries
Health care of older people
Justice healthcare
Neurological health
Nursing care
Prehospital and emergency care
Rehabilitation and related therapies
Vaccines
None of the above
Other (please specify)
4
. Are you willing to consider discussing or commenting on problems related to protocols or draft reviews in your areas of interest?
Are you willing to consider discussing or commenting on problems related to protocols or draft reviews in your areas of interest?
Yes
No
Maybe
Other (please specify)
5
. Do you know of any publications or ongoing research (including your own) that the Adverse Effects Methods group should be aware of (other than those listed on our website http://aemg.cochrane.org/relevant-publications)?
Do you know of any publications or ongoing research (including your own) that the Adverse Effects Methods group should be aware of (other than those listed on our website http://aemg.cochrane.org/relevant-publications)?
6
. Have you any suggestions for how the Cochrane Adverse Effects can improve its work or help you with yours?
Have you any suggestions for how the Cochrane Adverse Effects can improve its work or help you with yours?
7
. Please tell us your contact details (optional).
Please tell us your contact details (optional).
Name:
Email:
Powered by
SurveyMonkey
Check out our
sample surveys
and create your own now!
Javascript is required for this site to function, please enable.